Dr. James M Poss, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3900 N Buffalo St, Orchard Park, NY 14127 Phone: 716-823-4962 Fax: 716-823-4962 |
Dr. Alexander Kendrat Mandych, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3075 Southwestern Blvd, Suite 102, Orchard Park, NY 14127 Phone: 716-675-0616 Fax: 716-675-7101 |
Dr. Jonathan Charles Vogan, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3075 Southwestern Blvd, Suite 102, Orchard Park, NY 14127 Phone: 716-675-0616 Fax: 716-675-7101 |
Dr. Natalka Daria Stachiw, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3670 South Benzing Rd, Suite C, Orchard Park, NY 14127 Phone: 716-675-5711 Fax: 716-675-1358 |
Frederick Carlton Gass, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3075 Southwestern Blvd, Suite 102, Orchard Park, NY 14127 Phone: 716-675-0616 Fax: 716-675-7101 |
Heather Fenley Crabtree, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3670 S Benzing Rd Ste C, Orchard Park, NY 14127 Phone: 215-300-2577 |
Dr. Michael John Cipolla, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3670 South Benzing Rd, Suite C, Orchard Park, NY 14127 Phone: 716-675-5711 Fax: 716-675-1358 |
News Archive
Scientists from Nanyang Technological University, Singapore have developed a type of imaging probe that allows for earlier detection of acute kidney failure, a rapidly-developing condition that can be fatal.
An analysis of patients with a syndrome similar to the genetic disorder, neurofibromatosis type 1, indicates that diagnosis may be difficult because of shared clinical findings, such as certain pigmentary characteristics, according to a study in the November 18 issue of JAMA.
People up to age 40 living in economically depressed municipalities in the Greater Santiago, Chile, metropolitan area were three times more likely to die as a result of the infection than their counterparts in wealthier areas, researchers report in the journal Science.
The U.S. Food and Drug Administration (FDA) has announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.
› Verified 2 days ago